Valuation: PolyPeptide Group AG

Capitalization 130.94Cr 151.2Cr 120.14Cr 113.04Cr 210.53Cr 14TCr 213.83Cr 1.43TCr 555.78Cr 6.97TCr 567.72Cr 555.37Cr 24TCr P/E ratio 2026 *
78.6x
P/E ratio 2027 * 33.8x
Enterprise value 141.57Cr 163.47Cr 129.9Cr 122.21Cr 227.62Cr 16TCr 231.18Cr 1.54TCr 600.9Cr 7.53TCr 613.8Cr 600.45Cr 26TCr EV / Sales 2026 *
2.95x
EV / Sales 2027 * 2.63x
Free-Float
39.12%
Yield 2026 *
-
Yield 2027 * 0.07%
1 day-3.45%
1 week-3.96%
Current month-3.96%
1 month-8.66%
3 months+46.48%
6 months+47.07%
Current year+39.46%
1 week 36.15
Extreme 36.15
39.35
1 month 36.15
Extreme 36.15
41.7
Current year 23.1
Extreme 23.1
41.7
1 year 19.62
Extreme 19.62
41.7
3 years 13.22
Extreme 13.22
41.7
5 years 13.22
Extreme 13.22
147.4
10 years 13.22
Extreme 13.22
147.4
Manager TitleAgeSince
Chief Executive Officer 54 12/04/2023
Director of Finance/CFO 54 02/01/2024
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 72 01/01/2021
Chairman 69 01/04/2021
Director/Board Member 73 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
13/23/13Buy 2,500 0.0075%
12/23/12Buy 1,59,959 0.4829%
06/23/06Buy 45,842 0.1384%
Change 5d. change 1-year change 3-years change Capi.($)
-3.45%-3.96%+74.16%+51.67% 151.2Cr
+0.55%+2.39%+47.77%+154.68% 1,00900Cr
+2.02%+3.30%+51.48%+47.03% 56TCr
+1.02%+4.37%+21.21%+66.03% 40TCr
+0.77%-0.67%+22.19%+12.23% 33TCr
+2.24%+0.41%+29.51%+17.50% 29TCr
+1.85%+0.14%+22.04%+30.54% 27TCr
+4.43%-3.11%-40.46%-47.48% 19TCr
+1.15%+3.80%+21.76%+57.55% 19TCr
-0.02%-3.92%+16.93%+66.19% 16TCr
Average +0.72%+0.63%+26.66%+45.59% 34.03TCr
Weighted average by Cap. +0.63%+1.94%+31.26%+70.11%

Financials

2026 *2027 *
Net sales 48Cr 55Cr 44Cr 41Cr 77Cr 5.28TCr 78Cr 523.61Cr 203.78Cr 2.55TCr 208.16Cr 203.63Cr 8.88TCr 55Cr 64Cr 50Cr 47Cr 88Cr 6.05TCr 90Cr 599.88Cr 233.46Cr 2.93TCr 238.48Cr 233.29Cr 10TCr
Net income 1.65Cr 1.91Cr 1.52Cr 1.43Cr 2.66Cr 181.71Cr 2.7Cr 18Cr 7.01Cr 88Cr 7.16Cr 7Cr 305.59Cr 4.11Cr 4.75Cr 3.77Cr 3.55Cr 6.61Cr 452.26Cr 6.71Cr 45Cr 17Cr 218.72Cr 18Cr 17Cr 760.6Cr
Net Debt 11Cr 12Cr 9.75Cr 9.18Cr 17Cr 1.17TCr 17Cr 115.92Cr 45Cr 565.6Cr 46Cr 45Cr 1.97TCr 14Cr 16Cr 13Cr 12Cr 22Cr 1.51TCr 22Cr 149.34Cr 58Cr 728.66Cr 59Cr 58Cr 2.53TCr
Logo PolyPeptide Group AG
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Employees
1,440
Date Price Change Volume
05/26/05 36.40 CHF -3.45% 52,676
04/26/04 37.70 CHF +1.34% 66,977
03/26/03 37.20 CHF -2.87% 33,389
02/26/02 38.30 CHF +1.19% 26,336
01/26/01 37.85 CHF -0.13% 54,284
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
39.67EUR
Average target price
39.11EUR
Spread / Average Target
-1.42%

Quarterly revenue - Rate of surprise